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A C C E P T E D M
A N U S C R I P T neurological complications including encephalitis, acute myelitis, encephalopathy, seizures, meningitis, and meningoencephalitis [1, 2, [7] [8] [9] . ZIKV infection of pregnant women causes microcephaly probably because the virus infects neural progenitor and glial cells, inducing apoptosis and excitotoxic cell death [10] , apparently reaching the CNS via endothelial cells without damaging the blood-brain barrier [11] . Childhood stroke from ZIKV vasculitis [12] may result from infection of brain endothelial cells. The neurological complications of the Zika epidemic led the WHO to declare Zika a "public health emergency of international concern" [13] . On November 18, 2016 , WHO declared the end of the global health emergency; however, the global risk assessment over the spread of ZIKV remains unchanged.
The Zika virus epidemic
ZIKV was first isolated in 1947 in a Rhesus monkey in the Ziika forest in Uganda, and the first serology-confirmed human cases of ZIKV infection were reported in Africa in 1952 [14] . The current outbreak of ZIKV originated in the island of Yap, Micronesia, in June 2007 [15, 16] . This Flavivirus was considered clinically unimportant given that only 14 human symptomatic cases had been reported between 1947 and 2006 [17] . From Micronesia, the Zika epidemic spread to French Polynesia in 2013-2014 and then to other Pacific islands [2] . In May 2015, the first cases in the Americas were reported in northeastern Brazil followed by rapid spread of the virus throughout the Western Hemisphere [2] . In August 2016, the Pan American Health Organization (PAHO) reported 578,148 suspected cases of ZIKV in 45 countries and territories [18] , from the southern USA to Brazil and northern Argentina (excluding continental Chile) potentially exposing 500 million people.
The neurological complications of ZIKV infection have been extensively reviewed [1, 2, 8, 9] . In 2013, during the first large outbreak of Zika in French Polynesia, CaoLormeau et al [19] documented the occurrence of GBS post-ZIKV infection. In 2015, local transmission of ZIKV was reported in Brazil [2] ; in December 2015 it reached Colombia and by epidemiological week 28 of 2016 a total of 99,721 cases were registered [18] . In February 2016, almost 90 cases of GBS were reported [20, 21] triplicating in 3 months the number of cases observed during the previous six years [22, 23] . Other neurological complications, including transverse myelitis (TM) and acute disseminated encephalomyelitis (ADEM), were documented also [1, 2] .
A C C E P T E D M
A N U S C R I P T
Methods
We conducted a search of the medical literature for reports of neurological complications of Zika infection in the Americas and the Caribbean, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [24] via PubMed until May 2018. We used the following key terms: ("Guillain-Barré 
Neurological Complications of ZIKV infection: Case report
We report an illustrative case of a young woman from Cúcuta (Northeast Colombia) with ZIKV infection and evidence of arboviral immunity against CHIKV and DENV acquired prior to the arrival of Zika in Colombia. This patient developed acute Zika plus concurrent GBS, TM and ZIKV-associated encephalitis leading us to postulate potential mechanisms that could be associated with these extensive neurological complications of ZIKV infection. The geographical characteristics, neuroepidemiology, immunology, and neurological manifestations of the Zika outbreak in Cúcuta, Colombia, were previously described by two of us (JMA, YR) [2, 7] . This case was previously listed as radiculomyelopathy [7] 
A C C E P T E D M A N U S C R I P T
above pattern is consistent with acute motor axonal neuropathy (AMAN), as previously reported in ZIKV-associated GBS in French Polynesia [19] , Brazil [8] , and Colombia [5, 6, 7] .
About one month after onset, MRIs of the brain and spinal cord were performed.
Brain MRI on T2 and fluid-attenuated inversion recovery (FLAIR) sequences disclosed multifocal non-enhancing hyperintense lesions located in the periventricular white matter and subcortical areas [ Figure 1A ,B]. MRI of the cervical, thoracic, and lumbar spine, with and without gadolinium contrast, demonstrated multiple T2 hyperintense, nonenhancing lesions in the medulla oblongata, cervical and thoracic spinal cord [ Figure   2A ,B]. In summary, the clinical presentation, neurophysiology tests, and MRI lesions confirmed the presence of ZIKV-associated ADEM + GBS.
The patient remained in ICU for six weeks requiring respiratory support, nasogastric tube feeding and treatment for numerous complications including antibioticresistant Acinetobacter baumannii septicemia and basal pneumonia. Eventually, she was weaned from the respirator; her level of alertness improved, and she was able to communicate. On neurological examination, she had residual unilateral optic neuritis, 
Discussion
This case highlights several important aspects of the neurological manifestations of ZIKV including the concurrent development of GBS and encephalomyelitis during the acute phase of the ZIKV infection demonstrated by RT-PCR. It has been reported in the literature that the neurological complications of ZIKV infection can be either parainfectious, i.e., due to direct viral neurotropism, or post-infectious, i.e., resulting from immune-mediated reactions against the virus. We review the original descriptions of A C C E P T E D M A N U S C R I P T para-infectious, post-infectious and post-vaccination neurological syndromes and summarize the reported cases of TM and ADEM in the American continent. We conclude by discussing the implications of the presence in our patient of serological evidence of immunity against CHIKV and DENV suggesting that preexistent arboviral immunity could be relevant to the coexistence of widespread neurological involvement of both PNS and CNS in this patient.
Para-infectious, post-infectious and post-vaccination neurological syndromes
In 1956, Miller, Stanton and Gibbons [27] reviewed the para-infectious encephalomyelitis and related syndromes occurring simultaneously or shortly after the onset of an acute viral infection such as mumps, which is capable of causing ADEM [28] and other immune responses affecting the brain, spinal cord as well as the peripheral nervous system (PNS). It is generally accepted that viral neurotropism is the main mechanism of injury. Recent examples include the polio-like complications of WNV [29] and of enterovirus D68 strain [30, 31] .
In 1969, Charles Poser [32] in a now-classic paper proposed the term "acute disseminated vasculomyelinopathy" to designate some post-infectious and postvaccination neurological complications affecting both the central nervous system (CNS) and the PNS after a period of latency ranging from a few days to several weeks [33] . He emphasized that these immune reactions in the CNS are characterized neuropathologically by perivenous vascular inflammation frequently affecting the myelin.
Post-infectious reactions following varicella and rubella may involve the brain itself, spinal cord, spinal roots, and peripheral nerves, manifested by various clinical syndromes such as ADEM, optic neuritis, papilledema, isolated ophthalmoplegia, brachial neuritis and other mononeuropathies.
Guillain-Barré syndrome (GBS)
GBS has been considered a post-infectious complication associated with production of antibodies against peripheral nerve gangliosides and other components of axons, myelin or nerve roots [34] , occurring after gastrointestinal and upper respiratory tract infections caused by bacterial agents such as Campylobacter jejuni, Mycoplasma pneumoniae, and at least 10 other bacterial microorganisms [34] . GBS occurred also with increased incidence following swine flu vaccination [35] . Viral infections associated with GBS [34] include cytomegalovirus (CMV), herpes simplex virus, varicella-zoster A C C E P T E D M A N U S C R I P T virus, Epstein-Barr virus (EBV), hepatitis B virus, human immunodeficiency virus, and parainfluenza type-3 virus [36] . Acosta-Ampudia et al [2] , have emphasized that arboviral infections -including ZIKV-alter the immune recognition of peripheral nerve, possibly causing the myelin and underlying axon not to be recognized as self-tissue, leading to abnormal autoimmune responses and GBS. Among the flaviviruses, Dengue infections [37, 38] , particularly the neurotropic serotypes DENV-2 and DENV-3 [39] , have been associated with GBS and other neurological complications [40] , including meningoencephalitis, ADEM [41] , cerebellar syndrome, neuromyelitis optica, as well as a longitudinally extensive form of TM [42] .
Prior to the current ZIKV pandemic it was believed that the latency period following infection was required for the production of antibodies cross-reacting by molecular mimicry with epitopes in peripheral nerves leading to myelin or axonal injury.
Thus, Anaya et al [7] in Cúcuta (Colombia) found a lag time of 7 days (interquartile range 2-14.5) between ZIKV infection and neurological symptoms. The incidence of GBS increased 4.41-fold secondary to ZIKV infection. Serum anti-ganglioside antibodies were found in 71.43% of patients with acute inflammatory demyelinating polyneuropathy (AIDP) and in 14.28% of patients with axonal forms (AMAN). Anaya and colleagues [7] performed a case-control study comparing 29 patients with ZIKV-GBS and 74 matchedcontrols with ZIKV infection alone and found that all GBS patients were positive for IgG antibodies against both ZIKV and DENV, and 69% were positive also for CHIKV [7] .
Previous infection with M. pneumoniae increased 4-fold the risk of GBS (OR: 3.95; 95% CI=1.44-13.01; p=0.006). No differences in antibody levels against C. jejuni, EBV and CMV were observed [7] .
Based on their experience in French Polynesia, Gérardin et al. [43] postulated that Zika-related GBS might have a different mechanism than the usual post-viral GBS.
They suggested that a hyperacute immune response potentially occurs in patients who are Dengue seropositive since there is cross-reactivity of DENV with ZIKV [44] . In Colombia, Parra et al [6] concluded that 48% of the cases of ZIKV-GBS had parainfectious onset. As reported by Anaya et al [7] , the presence of serological evidence of immunity against CHIKV and DENV in 100% of their ZIKV-GBS cases diagnosed in Colombia, as illustrated here, would support the proposal of Gérardin et al [43] from French Polynesia, resulting in hyperacute immune response shortening the time between ZIVK infection and onset of neurological manifestations.
A C C E P T E D M A N U S C R I P T
Nonetheless, Timmings and colleagues [45] from New Zealand favor a direct neurotropic effect of ZIKV on peripheral nerves as a possible para-infectious mechanism of action. Their patient was a man infected in Tonga (South Pacific Polynesia) who developed GBS concurrently with demonstrated Zika viremia but with negative ZIVK isolation in the CSF and serological absence of previous viral antibodies against Dengue and other flaviviruses; MRIs of brain and spinal cord were normal [46] . The two mechanisms may be at play in different environments and further studies will be required to define the actual pathogenesis of ZIKV-associated GBS.
Acute transverse myelitis (ATM) and acute disseminated encephalomyelitis (ADEM)
ZIKV-ATM and ZIKV-ADEM have rarely been reported in the American continent and the Caribbean [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] . We were able to find a total of 19 patients with myelitis associated with ZIKV infection [ Table 2 ]. Clinically, these cases can be separated in the following Given the delay between the acute ZIKV infection and the onset of neurological symptoms (14 days), a diagnosis of post-infectious ZIKV-EM was proposed [54] . 
The Role of Other Arboviral Infections

ZIKV-GBS, transverse myelitis and encephalomyelitis: Para-infectious or Postinfectious
The possible pathogenesis of ZIKV-associated neurological disorders has been recently reviewed [1, 2, 8, 10, 61] . Miner and Diamond [59] postulated that congenital ZIKV infection might be related to the high prevalence of pre-existing cross-reactive immune responses associated with DENV [44] . Similar observations in GBS patients from
French Polynesia [43] and Colombia [6, 7] suggest that a hyperacute immune response may occur resulting in para-infectious onset. Serological evidence of previous immunity against both CHIKV and DENV was found in Colombia [7, 8] . Nevertheless, as reported by Anaya et al [8] , no significant differences for arboviruses (i.e., DENV and CHIKV)
between GBS cases and controls were observed but GBS cases more frequently had evidence of prior M. pneumoniae infection. These observations reinforce the view that the neurotropism of ZIKV may cause the simultaneous compromise of CNS and PSN [45, 46] . In Brazil, da Silva and colleagues [49] found that 50% of ZIKV-encephalitis cases also have neuromuscular findings and almost half of the patients with ZIKVassociated GBS present enhancement of cranial nerves on MRI scans manifested by dysphagia and facial numbness. Moreover, a variety of ZIKV-GBS subtypes occurred including AIDP, AMAN, acute motor and sensory axonal neuropathy, and Miller Fisher syndrome variant [1, 7, 8, 49] . A purely sensory polyneuropathy has also been reported [62] . In situ hybridization showed meningeal, germinal matrix, and neocortical ZIKV infection.
A secondary ischemic process was also present. Bardina et al [72] in a murine model of ZIVK infection described increased morbidity and mortality following the injection of convalescent plasma from DENV-or WNV-infected mice; plasma injections caused marked viremia, high fever, and increased ZIKV viral load in spinal cord and testes.
These authors [72] proposed an antibody-dependent enhancement (ADE) mechanism mediated in vitro through IgG engagement of Fc-Gamma receptors to potentiate the ZIKV infection.
In summary, the current Zika epidemic has resulted in unexpected increase in the incidence of microcephaly and other congenital neurological defects as well as ZIKV-GBS in adults. We report a case of simultaneous ZIKV-associated ADEM+GBS indicative of the potential of ZIKV to affect CNS and PNS concurrently. ZIKV infection 
